| EMA number | EMEA/H/C/002814 |
| ATC code | B01 |
| Authorisation | 19 January 2015 |
| Withdrawn | 23 June 2017 |
| Revision | 2 |
Zontivityis indicated for the reduction of atherothrombotic events in adult patients with a history of myocardial infarction (MI), ,co-administered with acetylsalicylic acid (ASA) and, where appropriate, clopidogrel; or symptomatic peripheral arterial disease (PAD), co-administered with acetylsalicylic acid (ASA) or, where appropriate, clopidogrel.